[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Yadav et al., 2018 - Google Patents

Liquid biopsy in pancreatic cancer: the beginning of a new era

Yadav et al., 2018

View HTML
Document ID
6064585242101531447
Author
Yadav D
Bai X
Yadav R
Singh A
Li G
Ma T
Chen W
Liang T
Publication year
Publication venue
Oncotarget

External Links

Snippet

With dismal survival rate pancreatic cancer remains one of the most aggressive and devastating malignancy. Predominantly, due to the absence of a dependable methodology for early identification and limited therapeutic options for advanced disease. However, it …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6802—General aspects

Similar Documents

Publication Publication Date Title
Yadav et al. Liquid biopsy in pancreatic cancer: the beginning of a new era
Urabe et al. Extracellular vesicles as biomarkers and therapeutic targets for cancer
Zhang et al. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives
Pantel et al. Circulating tumour cells in cancer patients: challenges and perspectives
Samandari et al. Liquid biopsies for management of pancreatic cancer
Zhang et al. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes
Nordgård et al. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer
Xie et al. Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non–small-cell lung cancer patients
Thiele et al. Circulating tumor cells: fluid surrogates of solid tumors
Cho et al. Gene expression signature–based prognostic risk score in gastric cancer
Labib et al. Circulating tumor cell profiling for precision oncology
Ferlizza et al. The roadmap of colorectal cancer screening
Zhang et al. Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
Belotti et al. Microfluidics for liquid biopsies: recent advances, current challenges, and future directions
Wurdinger et al. Platelet RNA as pan-tumor biomarker for cancer detection
Jenkinson et al. Biomarkers for early diagnosis of pancreatic cancer
Herath et al. The role of circulating biomarkers in lung cancer
Nanduri et al. The prognostic role of circulating tumor cells in colorectal cancer
Dong et al. Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis
Gužvić et al. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes
Morrison et al. Development and application of liquid biopsies in metastatic prostate cancer
Raufi et al. Advances in liquid biopsy technology and implications for pancreatic cancer
Barger et al. Extracellular miRNAs as biomarkers in cancer
Li et al. The emerging role of circulating tumor cells in cancer management
Schreyer et al. Deconstructing pancreatic cancer using next generation-omic technologies–from discovery to knowledge-guided platforms for better patient management